# V1 Empirics Check — x-ai/grok-4.1-fast (Variant C)

**Model:** x-ai/grok-4.1-fast
**Variant:** C
**Date:** 2026-04-02T13:15:31.294425

---

### 1. Idea Fidelity
The paper partially pursues the original idea manifest but falls substantially short on key elements. It faithfully implements the core identification strategy (judge-leniency IV via Caseflow ACD random assignment), data source (public BVA text files from va.gov, parsed for VLJ names/outcomes), and initial research question (VLJ discretion in appeals). However, it completely misses the manifest's primary outcomes—veteran mortality, healthcare utilization, employment, and housing stability (via VA/SSA/QWI/LEHD/CDC data links)—delivering only a first-stage validation rather than causal effects of benefit receipt. This transforms a full causal paper into an instrument cookbook, undermining the "READY" feasibility grade and policy relevance for marginal veterans.

### 2. Summary
This paper constructs a novel judge-leniency instrument from quasi-random assignment of ~11,400 VA disability appeals (FY2017–2018) to 106 Veterans Law Judges, documenting a strong first stage (β=0.784, F=225) with excellent balance tests (joint p=0.999). It uncovers a "subjectivity premium": judge effects are largest (~1-for-1) for mental health claims and smallest for mechanical increased-rating appeals. The design credibly validates the instrument for future work on benefit effects but stops short of estimating downstream outcomes.

### 3. Essential Points
1. **Missing second stage**: The manifest promises causal estimates on mortality, employment, etc., but the paper provides only first-stage validation. This is not an AER: Insights paper—it's a methodological appendix. Authors must either add linked outcomes (feasible per manifest's smoke test) or retitle/reframe as "A New Instrument for VA Appeals" and explicitly position as enabling future research. Without this, reject outright.
   
2. **Overstated VLJ grant rate dispersion**: Text claims VLJ rates range 0.107–0.913, but summary stats show 0.094–0.592 (LOO: 0.077–0.594). If the 0.913 figure is real (e.g., from full sample including low-caseload judges), clarify; otherwise, correct typo. Magnitude β=0.78 implies a shift from strictest (~0.08) to lenient (~0.59) raises grant probability by ~40pp (from 33% mean), pushing some compliers near 100%—plausible but requires bounds/discussion of truncation (e.g., via Frandsen-type tests).

3. **Subsample fragility in heterogeneity**: Increased-rating (N=428, β=0.407, SE=0.242, p=0.09) and other small bins risk power issues; mental health (N=2,536) drives the "subjectivity premium" narrative. Run full interactions (leniency × issue FE) in pooled sample with VLJ-clustered SEs to test gradient formally; report power calculations. Joint F across categories is essential.

### 4. Suggestions
**Strengths to build on**: Excellent execution overall—F=225 is elite (beats Maestas et al. 2013's F~10–50); balance p=0.999 and remand placebo (β=-0.384) are gold-standard diagnostics; robustness suite (cross-year leniency F=21, LOJ SD=0.006) is comprehensive and transparent. Parsing details/reproducibility (GitHub-ready) suit AER: Insights. Subjectivity premium is novel/economically sharp, echoing Cabral et al. (2025) gradients.

**Data/empirics expansions (priority for revision)**:
- Extend sample: Manifest notes 40K–85K decisions/year; FY2017–18 transition (AMA 2017) may confound—add FY2019–22 (post-AMA stability) for 50K+ obs, testing pre/post ACD changes. Report VLJ caseload evolution (e.g., fig of grant rates over time).
- Formalize heterogeneity: Replace Table 3 subsamples with:
  ```
  Grant_i = α + β Z_j + ∑_k γ_k (Z_j × Issue_k) + FE + ε_i
  ```
  Test H0: γ_mental = γ_increased (expect reject); plot predicted grant probs by leniency quantile × issue.
- Instrument diagnostics: Add Angrist-Pischke F for multi-instrument (if VLJ FE); Frandsen (2023) complier prob bounds (monotonicity OK, but check defiers via judge-rank correlations). Compute residualized judge FE variance (as in Dobbie et al. 2018) for economic magnitude.
- Balance enhancements: Add figs (binned scatter leniency vs. covariates); test RO × issue interactions (singleton drops noted—use RO dummies only if N>5/case).

**Magnitudes/SEs**: All plausible/appropriate. SD(leniency)=0.095 yields SDE=0.159 (large per app. Table 5)—9pp IQR shift = 29% relative effect on grants, matching criminal leniency papers (e.g., Kling 2006 β~0.6–0.9). VLJ clustering correct (N_g=106>>20 rule); two-way conservative (SE=0.075 still F=108). For subsamples, Wild bootstrap SEs if N_j small.

**Writing/presentation**:
- Intro: Lead with policy stakes ($130B program, 100K backlog); quantify lottery ("75th vs. 25th percentile VLJ: +9pp grant = +$15K/year for 50% compliers").
- Tables: Unify (e.g., Table 2 balance needs controls matching Table 1); add col for partial R²_judge (~4%, as noted). Landscape Table 4 robustness.
- Discussion: Strengthen policy—appellate compliers (persisters post-RO denial) differ from initial-stage (Silver 2026); simulate reform (e.g., "AI triage reduces subjectivity premium by 50%?"). Caveat: No veteran IDs, so no direct outcome links yet—propose FOIA/VA DRN for mortality.
- Length: Trim institutional (move AMA lanes to footnote); expand SDE app. to all outcomes if added.

**Broader impact**: This is publishable post-revision—strongest new IV since Chyn (2024) patents. Pair with outcomes paper (e.g., +5pp mortality drop?); generalize to other dockets (e.g., immigration). Reproducibility badge easy. Total: Solid foundation, but deliver the causal punch for Insights.
